Search results for 'Embryonic stem cells Law and legislation' (try it on Scholar)

999 found
Sort by:
  1. Judit Sándor & Violeta Beširević (eds.) (2009). Perfect Copy?: Law and Ethics of Reproductive Medicine. Cenger for Ethics and Law in Biomedicine.score: 819.0
     
    My bibliography  
     
    Export citation  
  2. Minou Bernadette Friele (2008). Rechtsethik der Embryonenforschung: Rechtsharmonisierung in Moralisch Umstrittenen Bereichen. Mentis.score: 768.0
    Translate to English
    |
     
    My bibliography  
     
    Export citation  
  3. Patrick L. Taylor (2005). The Gap Between Law and Ethics in Human Embryonic Stem Cell Research: Overcoming the Effect of U.S. Federal Policy on Research Advances and Public Benefit. Science and Engineering Ethics 11 (4):589-616.score: 616.0
    Key ethical issues arise in association with the conduct of stem cell research by research institutions in the United States. These ethical issues, summarized in detail, receive no adequate translation into federal laws or regulations, also described in this article. U.S. Federal policy takes a passive approach to these ethical issues, translating them simply into limitations on taxpayer funding, and foregoes scientific and ethical leadership while protecting intellectual property interests through a laissez faire approach to stem cell patents (...)
    Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  4. Mi-Kyung Kim (2009). Oversight Framework Over Oocyte Procurement for Somatic Cell Nuclear Transfer: Comparative Analysis of the Hwang Woo Suk Case Under South Korean Bioethics Law and U.S. Guidelines for Human Embryonic Stem Cell Research. Theoretical Medicine and Bioethics 30 (5):367-384.score: 562.8
    We examine whether the current regulatory regime instituted in South Korea and the United States would have prevented Hwang’s potential transgressions in oocyte procurement for somatic cell nuclear transfer, we compare the general aspects and oversight framework of the Bioethics and Biosafety Act in South Korea and the US National Academies’ Guidelines for Human Embryonic Stem Cell Research, and apply the relevant provisions and recommendations to each transgression. We conclude that the Act would institute centralized oversight under governmental (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  5. A. -K. M. Andersson (2011). Embryonic Stem Cells and Property Rights. Journal of Medicine and Philosophy 36 (3):221-242.score: 487.2
    This article contributes to the current debate on human embryonic stem cell researchers’ possible complicity in the destruction of human embryos and the relevance of such complicity for the issue of commodification of human embryos. I will discuss if, and to what extent, researchers who destroy human embryos, and researchers who merely use human embryos destroyed by others, have moral use rights, and/or moral property rights, in these embryos. I argue that the moral status of the human embryo, (...)
    Direct download (11 more)  
     
    My bibliography  
     
    Export citation  
  6. William M. Sage (2010). Will Embryonic Stem Cells Change Health Policy? Journal of Law, Medicine and Ethics 38 (2):342-351.score: 472.8
    Embryonic stem cells are actively debated in political and public policy arenas. However, the connections between stem cell innovation and overall health care policy are seldom elucidated. As with many controversial aspects of medical care, the stem cell debate bridges to a variety of social conversations beyond abortion. Some issues, such as translational medicine, commercialization, patient and public safety, health care spending, physician practice, and access to insurance and health care services, are core health policy (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  7. Philip J. Nickel (2008). Ethical Issues in Human Embryonic Stem Cell Research. In Kristen Renwick Monroe, Ronald B. Miller & Jerome Tobis (eds.), Fundamentals of the Stem Cell Debate: The Scientific, Religious, Ethical & Political Issues. University of California Press.score: 445.6
    As a moral philosopher, the perspective I will take in this chapter is one of argumentation and informed judgment about two main questions: whether individuals should ever choose to conduct human embryonic stem cell research, and whether the law should permit this type of research. I will also touch upon a secondary question, that of whether the government ought to pay for this type of research. I will discuss some of the main arguments at stake, and explain how (...)
     
    My bibliography  
     
    Export citation  
  8. Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone (2011). Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury. Cell Stem Cell 8 (5):468-475.score: 444.0
    Geron recently announced that it had begun enrolling patients in the world's first-in-human clinical trial involving cells derived from human embryonic stem cells (hESCs). This trial raises important questions regarding the future of hESC-based therapies, especially in spinal cord injury (SCI) patients. We address some safety and efficacy concerns with this research, as well as the ethics of fair subject selection. We consider other populations that might be better for this research: chronic complete SCI patients for (...)
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  9. Frank Zenker (2010). Analyzing Social Policy Argumentation: A Case Study on the Opinion of the German National Ethics Council on an Amendment of the Stem Cell Law. Informal Logic 30 (1):62-91.score: 444.0
    This paper analyzes and evaluates the 2007 majority opinion of the German National Ethics Council which seeks to establish new information (as to the inferior quality of legally procurable human embryonic stem cells) as a sufficient reason for a relaxation of the 2002 Stem Cell Law. A micro-level analysis of the opinion’s central section is conducted and evaluated vis à vis the strongest known opponent position in the national debate at that time. The argumentation is claimed (...)
    Direct download (14 more)  
     
    My bibliography  
     
    Export citation  
  10. Dong‐Bo Ou, Hong‐Juan Lang, Rui Chen, Xiong‐Tao Liu & Qiang‐Sun Zheng (2009). Using Embryonic Stem Cells to Form a Biological Pacemaker Via Tissue Engineering Technology. Bioessays 31 (2):246-252.score: 432.0
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  11. Françoise Baylis (2009). For Love or Money? The Saga of Korean Women Who Provided Eggs for Embryonic Stem Cell Research. Theoretical Medicine and Bioethics 30 (5):385-396.score: 423.6
    In 2004 and 2005, Woo-Suk Hwang achieved international stardom with publications in Science reporting on successful research involving the creation of stem cells from cloned human embryos. The wonder and success all began to unravel, however, when serious ethical concerns were raised about the source of the eggs for this research. When the egg scandal had completely unfolded, it turned out that many of the women who provided eggs for stem cell research had not provided valid consents (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  12. Jan P. Beckmann (2004). On the German Debate on Human Embryonic Stem Cell Research. Journal of Medicine and Philosophy 29 (5):603 – 621.score: 420.0
    Germany since 1990 has one of the strictest human embryo protection laws, yet according to the Stem Cell Act of 2002 allows, under strict conditions, the import and use of human embryonic stem cells (hESC) for high priority research goals. The author tries to show how this is taken to be coherent by the parliamentary majority (though not necessarily by the general public) in Germany. In doing so, he firstly looks into the chronicle of the debate (...)
    Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  13. Joseph J. Fins & Madeleine Schachter (2002). Patently Controversial: Markets, Morals, and the President's Proposal for Embryonic Stem Cell Research. Kennedy Institute of Ethics Journal 12 (3):265-278.score: 420.0
    : This essay considers the implications of President George W. Bush's proposal for human embryonic stem cell research. Through the perspective of patent law, privacy, and informed consent, we elucidate the ongoing controversy about the moral standing of human embryonic stem cells and their derivatives and consider how the inconsistencies in the president's proposal will affect clinical practice and research.
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  14. Ingrid Brena Sesma (ed.) (2005). Células Troncales: Aspectos Científicos-Filosóficos y Jurídicos. Universidad Nacional Autónoma de México.score: 398.4
    Translate to English
    |
     
    My bibliography  
     
    Export citation  
  15. Laura Palazzani (2012). Embryo Research in Italy: The Bioethical and Biojuridical Debate. Human Reproduction and Genetic Ethics 17 (1):28-39.score: 384.0
    This article deals with the discussion on the status of the human embryo in Italy on a philosophical, socio-ethical and juridical level before, during and after the law (n. 40/2004). Different lines of thought are outlined and critically discussed. The focus is the debate over the so-called embryonic stem cells, pointing out the ethical premises and the juridical implications. The regulations in Italy are analysed in detail, referring to legislation and jurisprudence (showing analogies and differences). In (...)
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  16. Tuija Takala & Matti Häyry (2007). Benefiting From Past Wrongdoing, Human Embryonic Stem Cell Lines, and the Fragility of the German Legal Position. Bioethics 21 (3):150–159.score: 379.2
    This paper examines the logic and morality of the German Stem Cell Act of 2002. After a brief description of the law’s scope and intent, its ethical dimensions are analysed in terms of symbolic threats, indirect consequences, and the encouragement of immorality. The conclusions are twofold. For those who want to accept the law, the arguments for its rationality and morality can be sound. For others, the emphasis on the uniqueness of the German experience, the combination of absolute and (...)
    Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  17. Demetrio Neri (2011). The Race Toward 'Ethically Universally Acceptable' Human Pluripotent (Embryonic-Like) Stem Cells: Only a Problem of Sources? Bioethics 25 (5):260-266.score: 376.8
    Over the past few years, several proposals aimed at procuring human pluripotent (embryonic-like) stem cells without involving the destruction of a human embryo have been proposed and widely discussed. This article focuses on a basic aspect of the debate, namely the plausibility of one or more of these new proposals being able to meet the ethical requirements that those who regard the human embryo as sacred have tried to impose on stem cells research in the (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  18. David B. Resnik (2002). The Commercialization of Human Stem Cells: Ethical and Policy Issues. [REVIEW] Health Care Analysis 10 (2):127-154.score: 376.2
    The first stage of the human embryonic stem(ES) cell research debate revolved aroundfundamental questions, such as whether theresearch should be done at all, what types ofresearch may be done, who should do theresearch, and how the research should befunded. Now that some of these questions arebeing answered, we are beginning to see thenext stage of the debate: the battle forproperty rights relating to human ES cells. The reason why property rights will be a keyissue in this debate (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  19. Roman J. Krawetz, Xiangyun Li & Derrick E. Rancourt (2009). Human Embryonic Stem Cells: Caught Between a ROCK Inhibitor and a Hard Place. Bioessays 31 (3):336-343.score: 369.6
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  20. S. Aksoy (2005). Making Regulations and Drawing Up Legislation in Islamic Countries Under Conditions of Uncertainty, with Special Reference to Embryonic Stem Cell Research. Journal of Medical Ethics 31 (7):399-403.score: 368.4
  21. David Shaw (2014). Creating Chimeras for Organs is Legal in Switzerland. Bioethica Forum 14 (1).score: 366.4
    Switzerland has very detailed laws regulating the use of animals in agriculture, entertainment and science. There are also many Swiss laws governing the genetic modification of animals, protecting human embryos, and criminalising the creation of human/animal chimeras or hybrids. Despite all these regulations, the creation of an animal embryo that will develop a human organ using induced pluripotent stem cells and the subsequent birth of the resulting chimera would actually be permitted by current legislation. While this might (...)
    Direct download  
     
    My bibliography  
     
    Export citation  
  22. Nicholas Agar (2007). Embryonic Potential and Stem Cells. Bioethics 21 (4):198–207.score: 364.2
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  23. David B. Resnik (2007). Embryonic Stem Cell Patents and Human Dignity. Health Care Analysis 15 (3):211-222.score: 362.4
    This article examines the assertion that human embryonic stem cells patents are immoral because they violate human dignity. After analyzing the concept of human dignity and its role in bioethics debates, this article argues that patents on human embryos or totipotent embryonic stem cells violate human dignity, but that patents on pluripotent or multipotent stem cells do not. Since patents on pluripotent or multipotent stem cells may still threaten human dignity (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  24. Jackie Leach Scully & Christoph Rehmann-Sutter (2006). Creating Donors: The 2005 Swiss Law on Donation of 'Spare' Embryos to hESC Research. [REVIEW] Journal of Bioethical Inquiry 3 (1-2):81-93.score: 340.8
    In November 2004, the Swiss population voted to accept a law on research using human embryonic stem cells. In this paper, we use Switzerland as a case study of the shaping of the ostensibly ethical debate on the use of embryos in embryonic stem cell research by legal, political and social constraints. We describe how the national and international context affected the content and wording of the law. We discuss the consequences of the revised law's (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  25. Audrey R. Chapman & Courtney C. Scala (2012). Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy. Kennedy Institute of Ethics Journal 22 (3):243-261.score: 338.4
    The transition of novel and potentially promising medical therapies into their initial human clinical trials can engender conflicting pressures. On the one side, because Phase I trials raise greater ethical and human protection challenges than later stage clinical trials, there is a need to proceed cautiously. This is particularly the case for Phase I trials with a novel therapy being tested in humans for the first time, usually termed first-in-human (FIH) trials, especially if the FIH trial involves significant risks. On (...)
    Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  26. Godfrey B. Tangwa (2007). Moral Status of Embryonic Stem Cells: Perspective of an African Villager. Bioethics 21 (8):449–457.score: 338.4
  27. Andrew Fenton & Frederic Gilbert (2011). On the Use of Animals in Emergent Embryonic Stem Cell Research for Spinal Cord Injuries. Journal of Animal Ethics 1 (1):37-45.score: 331.2
    In early 2009, President Obama overturned the ban on federal funding for research involving the derivation of human embryonic stem cells (hESC). The Food and Drug Administration (FDA) also approved Geron’s first-in-human hESC trial for spinal cord injury (SCI) patients. We anticipate an increase in both research in the United States to derive hESC and applications to the FDA for approval of clinical trials involving transplantation of hESCs. An increase of such clinical trials will require a concomitant (...)
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  28. Fuat S. Oduncu (2003). Stem Cell Research in Germany: Ethics of Healing Vs. Human Dignity. [REVIEW] Medicine, Health Care and Philosophy 6 (1):5-16.score: 325.6
    On 25 April 2002, the German Parliament has passed a strict new law referring to stem cell research. This law took effect on July 1, 2002. The so-called embryonic Stem Cell Act ( Stammzellgesetz — StZG ) permits the import of embryonic stem (ES) cells isolated from surplus IvF-embryos for research reasons. The production itself of ES cells from human blastocysts has been prohibited by the German Embryo Protection Act of 1990, with the (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  29. Donna L. Dickenson (2006). The Lady Vanishes: What's Missing From the Stem Cell Debate. [REVIEW] Journal of Bioethical Inquiry 3 (1-2):43-54.score: 324.0
    Most opponents of somatic cell nuclear transfer and embryonic stem cell technologies base their arguments on the twin assertions that the embryo is either a human being or a potential human being, and that it is wrong to destroy a human being or potential human being in order to produce stem cell lines. Proponents’ justifications of stem cell research are more varied, but not enough to escape the charge of obsession with the status of the embryo. (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  30. Lawrence Burns (2009). “You Are Our Only Hope”: Trading Metaphorical “Magic Bullets” for Stem Cell “Superheroes”. Theoretical Medicine and Bioethics 30 (6):427-442.score: 316.8
    In the wake of two recent developments in stem cell research, it is a fitting time to reassess the claim that stem cells will radically transform the concept and function of medicine. The first is the U.S. Food and Drug Administration’s decision in January 2009 to approve Geron Corporation’s Phase I clinical trial using human embryonic stem cells for patients with spinal cord injuries. The second is the National Institutes of Health’s decision to permit (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  31. Melinda Cooper (2009). Regenerative Pathologies: Stem Cells, Teratomas and Theories of Cancer. [REVIEW] Medicine Studies 1 (1):55-66.score: 313.8
    What is now familiarly referred to as the ‘embryonic stem (ES) cell’ is a recent biological category whose origins lie in research into benign and malignant teratomas carried out in the 1950s, 60s and 70s. In these studies, the question of the normal or pathological character of the ES cell was a matter of considerable debate and indeed the term ES cell was often used interchangeably with that of the embryonal carcinoma (EC) cell. This article argues that the (...)
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  32. Hossam E. Fadel (2012). Developments in Stem Cell Research and Therapeutic Cloning: Islamic Ethical Positions, a Review. Bioethics 26 (3):128-135.score: 313.2
    Stem cell research is very promising. The use of human embryos has been confronted with objections based on ethical and religious positions. The recent production of reprogrammed adult (induced pluripotent) cells does not – in the opinion of scientists – reduce the need to continue human embryonic stem cell research. So the debate continues.Islam always encouraged scientific research, particularly research directed toward finding cures for human disease. Based on the expectation of potential benefits, Islamic teachings permit (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  33. Nicolae Ovidiu Grad, Ionel Ciprian Pop & Ion Aurel Mironiuc (2012). Stem Cells Therapy and Research. Benefits and Ethical Challences. Journal for the Study of Religions and Ideologies 11 (32):190-205.score: 310.8
    The research on stem cell-based therapies has greatly expanded in recent years. Our text attempts to seek those religious and ethical challenges that stem cell therapy and research bring into debate. Our thesis is that bioethics can defend its principle without a religious background. We will develop our argumentation on three major points: firstly, a comparison between secular ethics and religious views will clarify why stem cell therapy and research are important from a scientific point of view, (...)
    No categories
    Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  34. Mark Moller (2009). Human Embryonic Stem Cell Research and the Discarded Embryo Argument. Theoretical Medicine and Bioethics 30 (2):131-145.score: 300.0
    Many who believe that human embryos have moral status are convinced that their use in human embryonic stem cell (hESC) research can be morally justified as long as they are discarded embryos left over from fertility treatments. This is one reason why this view about discarded embryos has played such a prominent role in the debate over publicly funding hESC research in the United States and other countries. Many believe that this view offers the best chance of a (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  35. Erica Haimes & Ken Taylor (2011). The Contributions of Empirical Evidence to Socio-Ethical Debates on Fresh Embryo Donation for Human Embryonic Stem Cell Research. Bioethics 25 (6):334-341.score: 300.0
    This article is a response to McLeod and Baylis (2007) who speculate on the dangers of requesting fresh ‘spare’ embryos from IVF patients for human embryonic stem cell (hESC) research, particularly when those embryos are good enough to be transferred back to the woman. They argue that these embryos should be frozen instead. We explore what is meant by ‘spare’ embryos. We then provide empirical evidence, from a study of embryo donation and of embryo donors' views, to substantiate (...)
    Direct download (11 more)  
     
    My bibliography  
     
    Export citation  
  36. Matthew Herder (2006). Proliferating Patent Problems with Human Embryonic Stem Cell Research? Journal of Bioethical Inquiry 3 (1-2):69-79.score: 300.0
    The scientific challenges and ethical controversies facing human embryonic stem cell (hESC) research continue to command attention. The issues posed by patenting hESC technologies have, however, largely failed to penetrate the discourse, much less result in political action. This paper examines U.S. and European patent systems, illustrating discrepancies in the patentability of hESC technologies and identifying potential negative consequences associated with efforts to make available hESC research tools for basic research purposes while at same time strengthening the position (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  37. Søren Holm (2006). Who Should Control the Use of Human Embryonic Stem Cell Lines: A Defence of the Donors' Ability to Control. [REVIEW] Journal of Bioethical Inquiry 3 (1-2):55-68.score: 300.0
    In this paper I analyse who should be able to control the use of human embryonic stem cell lines. I distinguish between different kinds of control and analyse a set of arguments that purport to show that the donors of gametes and embryos should not be able to control the use of stem cell lines derived from their embryos. I show these arguments to be either deficient or of so general a scope that they apply not only (...)
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  38. Yves Maury, Morgane Gauthier, Marc Peschanski & Cécile Martinat (2012). Human Pluripotent Stem Cells for Disease Modelling and Drug Screening. Bioessays 34 (1):61-71.score: 291.6
    No categories
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  39. Samer Mi Hussein, Judith Elbaz & Andras A. Nagy (2013). Genome Damage in Induced Pluripotent Stem Cells: Assessing the Mechanisms and Their Consequences. Bioessays 35 (3):152-162.score: 291.6
    Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  40. Divya Rajamohan, Elena Matsa, Spandan Kalra, James Crutchley, Asha Patel, Vinoj George & Chris Denning (2013). Current Status of Drug Screening and Disease Modelling in Human Pluripotent Stem Cells. Bioessays 35 (3):281-298.score: 291.6
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  41. Anna M. Wobus (2010). The Janus Face of Pluripotent Stem Cells – Connection Between Pluripotency and Tumourigenicity. Bioessays 32 (11):993-1002.score: 291.6
    Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  42. Karen Lebacqz (2012). Stumbling on Status: Abortion, Stem Cells, and Faulty Reasoning. [REVIEW] Theoretical Medicine and Bioethics 33 (1):75-82.score: 284.4
    Common arguments from the abortion debate have set the stage for the debate on stem cell research. Unfortunately, those arguments demonstrate flawed reasoning—jumping to unfounded conclusions, using value laden language rather than careful argument, and ignoring morally relevant aspects of the situation. The influence of flawed abortion arguments on the stem cell debate results in failures of moral reasoning and in lack of attention to important morally relevant differences between abortion and human embryonic stem cells. (...)
    No categories
    Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  43. Catherine Waldby, Ian Kerridge & Loane Skene (2012). Multidisciplinary Perspectives on the Donation of Stem Cells and Reproductive Tissue. Journal of Bioethical Inquiry 9 (1):15-17.score: 282.6
    Multidisciplinary Perspectives on the Donation of Stem Cells and Reproductive Tissue Content Type Journal Article Category Symposium Pages 15-17 DOI 10.1007/s11673-011-9351-x Authors Catherine Waldby, School of Social and Political Sciences, University of Sydney, Sydney, Australia Ian Kerridge, Centre for Values, Ethics and the Law in Medicine, Medical Foundation Building (K25), University of Sydney, Sydney, NSW 2006, Australia Loane Skene, Faculty of Law and Faculty of Medicine, Dentistry and Health Studies, University of Melbourne, Melbourne, VA, Australia Journal Journal of (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  44. Roberta Berry, Lisa Bliss, Sylvia Caley, Paul Lombardo, Jerri Rooker, Jonathan Todres & Leslie Wolf (2010). Recent Developments in Health Care Law: Partners in Innovation. [REVIEW] HEC Forum 22 (2):85-116.score: 282.4
    This article reviews recent developments in health care law, focusing on the engagement of law as a partner in health care innovation. The article addresses: the history and contents of recent United States federal law restricting the use of genetic information by insurers and employers; the recent federal policy recommending routine HIV testing; the recent revision of federal policy regarding the funding of human embryonic stem cell research; the history, current status, and need for future attention to advance (...)
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  45. Nabeel Manzar, Bushra Manzar, Nuzhat Hussain, M. Fawwad Ahmed Hussain & Sajjad Raza (2013). The Ethical Dilemma of Embryonic Stem Cell Research. Science and Engineering Ethics 19 (1):97-106.score: 278.4
    To determine the knowledge, attitude, and ethical concerns of medical students and graduates with regard to Embryonic Stem Cell (ESC) research. This questionnaire based descriptive study was conducted at the Civil Hospital Karachi (CHK), Pakistan from February to July 2008. A well structured questionnaire was administered to medical students and graduate doctors, which included their demographic profile as well as questions in line with the study objective. Informed consent was taken and full confidentiality was assured to the participants. (...)
    Direct download (8 more)  
     
    My bibliography  
     
    Export citation  
  46. Aaron Rizzieri (2012). Stem Cell Research on Embryonic Persons Is Just. Journal of Bioethical Inquiry (Browse Results) 9 (2):195-203.score: 271.8
    Abstract I argue that embryonic stem cell research is fair to the embryo, even on the assumption that the embryo has attained full personhood and an attendant right to life at conception. This is because the only feasible alternatives open to the embryo are to exist briefly in an unconscious state and be killed or to not exist at all. Hence, one is neither depriving the embryo of an enduring life it would otherwise have had nor is one (...)
    Direct download (7 more)  
     
    My bibliography  
     
    Export citation  
  47. Ronald K. F. Fung & Ian H. Kerridge (2013). Uncertain Translation, Uncertain Benefit and Uncertain Risk: Ethical Challenges Facing First-in-Human Trials of Induced Pluripotent Stem (Ips) Cells. Bioethics 27 (2):89-96.score: 269.4
    The discovery of induced pluripotent stem (iPS) cells in 2006 was heralded as a major breakthrough in stem cell research. Since then, progress in iPS cell technology has paved the way towards clinical application, particularly cell replacement therapy, which has refueled debate on the ethics of stem cell research. However, much of the discourse has focused on questions of moral status and potentiality, overlooking the ethical issues which are introduced by the clinical testing of iPS cell (...)
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  48. Audrey R. Chapman (2009). The Ethics of Patenting Human Embryonic Stem Cells. Kennedy Institute of Ethics Journal 19 (3):pp. 261-288.score: 259.2
    Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  49. Jeffrey L. Ecker & Patricia Pearl O'Rourke (2007). An Immodest Proposal: Banking Embryonic Stem Cells for Solid Organ Transplantation is Problematic and Premature. American Journal of Bioethics 7 (8):48 – 50.score: 259.2
    Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
1 — 50 / 999